Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 EP1146 | DOI: 10.1530/endoabs.41.EP1146

1Trakya University Medical Faculty, Department of Endocrinology and Metabolizm, Edirne, Turkey; 2Trakya University Medical Faculty, Department of Pathology, Edirne, Turkey; 3Trakya University Medical Faculty, Department of Surgery, Edirne, Turkey; 4Trakya University Medical Faculty, Department of Nuclear Medicine, Edirne, Turkey.


Papillary thyroid cancer (PTC) constitutes 85% of all differentiated thyroid cancers. PTC is usually sporadic, but may occur in a familial form. Familial cancer syndromes such as Cowden’s syndrome and familial adenomatous polyposis are associated with PTC. Lal et al. recently published a study in which subsequent thyroid cancer was most common among the patients with renal cell cancer (RCC). RCC is a common malignancy of uroepithelial region, which constitutes about 3% of all adult malignancies. We presented 4 cases consecutively diagnosed with PTC and RCC within 12 months (Table). 3 cases with BRAF positivity had lymph node metastasis. The BRAF gene is located on chromosome 7. BRAF is a signaling protein downstream of Ras that activates the MAP-kinase pathway and implicated in cell differentiation and proliferation. Mutations of this gene have been found in cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, PTC and lung carcinoma, while few studies reported RCC cases with BRAF mutation. In 2016, Natasha Banerjee et al. reported a case with metastatic RCC and BRAF mutation, in whom a good clinical outcome was achieved following BRAF inhibition. BRAF positivity observed in 3 of our cases suggests that further studies are required on a common mutation that exists in RCC and PTC.

CASE 1CASE 2CASE 3CASE 4
Age64485667
GenderMaleMaleMaleMale
Clinic EuthyroidEuthyroidHyperthyroidHyperthyroid
PTC-variantClassic and follicularClassic and follicularClassic and oncocyticClassic, follicular and oncocytic
PTC-gradepT1a –pN1pT1a –pNxpT3a –pN1pT4a –pN1
FocalityMultifocalMultifocalMultifocalMultifocal
Metastasis+++
BRAF mutationV600E (+)Not analyzedV600E (+)V600E (+)
RAI (I-131)+++

Article tools

My recent searches

No recent searches.